Commonwealth Equity Services’s Neos Therapeutics, Inc NEOS Stock Holding History

Commonwealth Equity Services’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,100	Closed	-$8K	–	3500
2020 Q4	$8K	Sell	13,100 -500	-4%	-$309	﹤0.01%	3192
2020 Q3	$7K	Hold	13,600	–	–	﹤0.01%	3041
2020 Q2	$9K	Hold	13,600	–	–	﹤0.01%	2940
2020 Q1	$10K	Hold	13,600	–	–	﹤0.01%	2790
2019 Q4	$20K	Buy	13,600 +2,000	+17%	+$3K	﹤0.01%	2853
2019 Q3	$17K	Buy	+11,600	New	+$18.8K	﹤0.01%	2804
2018 Q4	–	Sell	-10,011	Closed	-$48K	–	2857
2018 Q3	$48K	Buy	+10,011	New	+$56.8K	﹤0.01%	2694

Commonwealth Equity Services's NEOS Position: Q1 2021 in Review

Commonwealth Equity Services sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 13,100 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in NEOS in Q3 2018 and held it in 7 quarters. The position peaked at $48K in Q3 2018. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Commonwealth Equity Services reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Commonwealth Equity Services sold 13,100 Neos Therapeutics, Inc shares in Q1 2021, an estimated $8K.
Commonwealth Equity Services first reported a position in Neos Therapeutics, Inc in Q3 2018 and held it in 7 quarters.
Commonwealth Equity Services's Neos Therapeutics, Inc position peaked at $48K in Q3 2018.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.